INSULIN DEGLUDEC Pharmacologic Class Indexing
- Class set ID
- 4d8c8818-a531-48ca-a375-32da560ef7ac
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use XULTOPHY 100/3.6 safely and effectively. See full prescribing information for XULTOPHY 100/3.6 . XULTOPHY ® 100/3.6 (insulin degludec and liraglutide) injection, for subcutaneous use Initial U.S. Approval: 2016 | Novo Nordisk | 20251014 | 14 |
| These highlights do not include all the information needed to use INSULIN DEGLUDEC safely and effectively. See full prescribing information for INSULIN DEGLUDEC. INSULIN DEGLUDEC injection, for subcutaneous use Initial U.S. Approval: 2015 This product is Tresiba (insulin degludec). | A-S Medication Solutions | 20240603 | 1 |
| These highlights do not include all the information needed to use INSULIN DEGLUDEC safely and effectively. See full prescribing information for INSULIN DEGLUDEC. INSULIN DEGLUDEC injection, for subcutaneous use Initial U.S. Approval: 2015 This product is Tresiba (insulin degludec). | A-S Medication Solutions | 20240531 | 1 |
| These highlights do not include all the information needed to use TRESIBA safely and effectively. See full prescribing information for TRESIBA. TRESIBA ® (insulin degludec) injection, for subcutaneous use Initial U.S. Approval: 2015 | A-S Medication Solutions | 20240222 | 1 |
| These highlights do not include all the information needed to use TRESIBA safely and effectively. See full prescribing information for TRESIBA. TRESIBA ® (insulin degludec) injection, for subcutaneous use Initial U.S. Approval: 2015 | A-S Medication Solutions | 20240201 | 1 |
| These highlights do not include all the information needed to use TRESIBA safely and effectively. See full prescribing information for TRESIBA. TRESIBA ® (insulin degludec) injection, for subcutaneous use Initial U.S. Approval: 2015 | A-S Medication Solutions | 20231212 | 11 |
| These highlights do not include all the information needed to use INSULIN DEGLUDEC safely and effectively. See full prescribing information for INSULIN DEGLUDEC. INSULIN DEGLUDEC injection, for subcutaneous use Initial U.S. Approval: 2015 This product is Tresiba (insulin degludec). | Novo Nordisk Pharma, Inc. | Novo Nordisk A/S | Novo Nordisk Pharmaceutical Industries, LP | 20220701 | 1 |
| These highlights do not include all the information needed to use TRESIBA safely and effectively. See full prescribing information for TRESIBA. TRESIBA ® (insulin degludec) injection, for subcutaneous use Initial U.S. Approval: 2015 | Novo Nordisk | 20220701 | 14 |